Sanai Health Group Reports Interim Loss Narrowed by 23.09%
Stock News
Aug 31
Sanai Health Group (01889) has released its financial results for the six months ended 30 June 2026, posting a loss attributable to shareholders of RMB 8.511 million, a year-on-year reduction of 23.09%.
During the period, the group generated revenue of RMB 43.923 million, reflecting a decline of 6.99% from the previous corresponding period. The loss per share stood at RMB 0.0557.
The company attributed the revenue drop primarily to Fujian Ruichuang, which sold pharmaceutical products with relatively lower profit margins during the reporting period, thereby reducing overall revenue figures.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.